PRESS RELEASES More events are coming soon. Keyword Search Year: 202120202019201820172016201520142013 05/05/21 Summary ToggleTRACON Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update Printer Friendly PDF Version 05/03/21 Summary ToggleTRACON Pharmaceuticals Announces Appointment of Dongliang Zhuang, Ph.D. as Vice President of Statistics and Biometrics Printer Friendly PDF Version 04/28/21 Summary ToggleTRACON to Report First Quarter 2021 Financial Results and Company Highlights on May 5, 2021 Printer Friendly PDF Version 03/23/21 Summary ToggleTRACON Pharmaceuticals Announces Poster Presentation at the 2021 AACR Virtual Annual Meeting Printer Friendly PDF Version 03/09/21 Summary ToggleTRACON Pharmaceuticals to Present at the Oppenheimer 31st Annual Healthcare Conference Printer Friendly PDF Version 03/08/21 Summary ToggleTRACON Pharmaceuticals Announces Appointment of Lisa Johnson-Pratt, M.D., to its Board of Directors Printer Friendly PDF Version 03/02/21 Summary ToggleTRACON Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference Printer Friendly PDF Version 02/25/21 Summary ToggleTRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update Printer Friendly PDF Version 02/18/21 Summary ToggleTRACON to Report Fourth Quarter and Full Year 2020 Financial Results and Company Highlights on February 25, 2021 Printer Friendly PDF Version 01/19/21 Summary ToggleTRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China for Priority Review Printer Friendly PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
